In fact, four of these top 54 proteins are novel to the AD field, with no literature directly linking these proteins to AD; two of these novel proteins were consistently increased in AD (CAPG and PBXIP1) and two were consistently decreased in AD (AP3D1 and SUCLA2). This evidence concerns the gene AP3D1 and Alzheimer disease.